Dolly the sheep's "siblings" are generally healthy, a study has shown, providing hope that cloning can yield animals free from degenerative illness.
The first mammal to be cloned from an adult cell - Dolly - died at the relatively young age of 6.5 years, having suffered from osteoarthritis.
This raised concerns that cloned animals might age more quickly.
But the new study, which tracked four sheep cloned from the same ewe as Dolly, found they had aged normally.
Some of the animals did show mild - and in one case moderate - signs of osteoarthritis. But the researchers say that it was not sufficiently severe that any of the animals required treatment.
When she was born on 5 July 1996, Dolly was the first animal to be cloned from an adult cell using a technique known as somatic-cell nuclear transfer (SCNT).
Writing in Nature Communications, a team led by Prof Kevin Sinclair at Nottingham University reports that the sheep Debbie, Denise, Dianna and Daisy reached their eighth birthdays in good health.
The Nottingham team based their conclusions on examination of Dolly's four "sisters" and nine other cloned sheep - all between seven and nine years of age.
"Healthy ageing of SCNT clones has never been properly investigated," said Prof Sinclair.
"Following our detailed assessments of glucose tolerance, insulin sensitivity, blood pressure and musculoskeletal investigations we found that our clones, considering their age, were at the time of our research healthy."
The researchers performed a battery of tests, including assessments of the animals' bones, joints and muscles, along with blood pressure measurements. They then compared these to "control" sheep aged between five and six years old.
They found no major health issues: there was no sign of metabolic disease, such as diabetes, in the clones and their blood pressure was normal.
The evidence of mild osteoarthritis in the clones - and a moderate case of the disease in Debbie - could be a normal feature of sheep as they age, the researchers write in their scientific paper.
Dolly's birth was a sensation when first announced to the world, and the technique that produced her was heralded as a way to develop new medical therapies or to save endangered species. But cloning is very inefficient. And even after 20 years of additional investigation, too many experiments yield no viable clone.
Prof Sinclair said the latest study offered a route to better understand why this was so, but conceded that SCNT still had a way to go to fulfil its promise.
He told BBC News: "And so there still remains an ethical and welfare concern with cloning and what we have to do is reduce the incidence of these losses to levels that approach those of natural conception before I think the technique would be widely accepted by the general public."
No comments:
Post a Comment